Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Liang Li's research, publications, and ongoing work
Identified the tumor-promoting role of EGFR in liver macrophages during the formation of hepatocellular carcinoma, providing insights into potential therapeutic targets.
Investigated the role of the lncRNA H19/miR-148a-3p/DNMT1 axis in regulating the progression of laryngeal squamous cell cancer, offering potential therapeutic avenues.
Performed single-cell and spatial transcriptome analysis to reveal the cellular heterogeneity of liver metastatic colorectal cancer, advancing the understanding of cancer progression.
Demonstrated that hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumor-associated macrophage recruitment, highlighting a key mechanism in tumor development.
Studied immune exhaustion of T cells in alveolar echinococcosis patients and its reversal by blocking checkpoint receptor TIGIT, offering potential therapeutic strategies.
Showed that tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Demonstrated that targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma.
Dr. Liang Li is a leading researcher in cancer immunotherapy and diagnostics, with significant contributions to understanding tumor microenvironments and developing novel therapeutic strategies. His work has advanced the field of precision medicine and improved patient outcomes.
Researchers with overlapping expertise and complementary work
Finding similar researchers...